Gene: EML5
Official Full Name: EMAP like 5provided by HGNC
Gene Summary: Predicted to enable microtubule binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18008 | EML5 Knockout cell line (HeLa) | Human | EML5 | 1:3~1:6 | Negative | Online Inquiry |
KO18009 | EML5 Knockout cell line (HCT 116) | Human | EML5 | 1:2~1:4 | Negative | Online Inquiry |
KO18010 | EML5 Knockout cell line (HEK293) | Human | EML5 | 1:3~1:6 | Negative | Online Inquiry |
EML5 Gene Knockout Cell Lines are a cutting-edge biotechnological tool developed to facilitate the study of gene function, cellular mechanisms, and disease models. These cell lines are engineered to have specific knockout mutations in the EML5 gene, which encodes an essential protein implicated in various cellular processes, including microtubule organization and cell division. By targeting this gene, researchers can investigate its role in oncogenesis and other pathological states, allowing for a deeper understanding of cellular dynamics and potential therapeutic targets.
The key function of EML5 Gene Knockout Cell Lines involves the precise alteration of the EML5 gene, enabling researchers to assess changes in cell behavior and signaling pathways. This model system allows for the analysis of resultant phenotypic alterations, thereby elucidating the gene's functional relevance in both normal physiology and disease conditions. The loss of EML5 expression can lead to significant changes in microtubule dynamics, impacting processes such as migration, proliferation, and response to external stimuli.
The scientific importance of these cell lines is underscored by their versatile application in both research and clinical settings. They serve as indispensable tools in cancer research, drug discovery, and development of targeted therapies. By providing insight into the molecular underpinnings of diseases associated with EML5, these knockout cell lines are instrumental in advancing our understanding of precision medicine approaches.
What sets EML5 Gene Knockout Cell Lines apart is their high specificity and reproducibility, making them a superior choice compared to conventional models like wild-type cell lines or less targeted knockout systems. Researchers gain the advantage of studying the direct effects of the EML5 gene absence without the confounding influences of off-target mutations. Furthermore, these cell lines come with comprehensive validation data, ensuring reliability and accuracy in experimental outcomes.
For researchers and clinicians focused on advancing genetic understanding in health and disease, the EML5 Gene Knockout Cell Lines represent an invaluable resource. Their unique capability to unravel complex biological queries solidifies their place as a pivotal component in the toolkit of modern molecular biology.
As a company dedicated to excellence in biological products, we leverage advanced engineering and rigorous quality control to provide research-grade tools, enabling scientists to accelerate discoveries and improve human health outcomes. Our expertise in gene editing technologies positions us as a leader in the field, ensuring that our customers receive top-tier products that empower their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.